| Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study CH Kawas, RC Kim, JA Sonnen, SS Bullain, T Trieu, MM Corrada Neurology 85 (6), 535-542, 2015 | 246 | 2015 |
| Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study MM Corrada, KM Hayden, A Paganini-Hill, SS Bullain, J DeMoss, ... Alzheimer's & dementia 13 (2), 103-110, 2017 | 171 | 2017 |
| Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal … O Szentirmai, CH Baker, N Lin, S Szucs, M Takahashi, S Kiryu, AL Kung, ... Neurosurgery 58 (2), 365-372, 2006 | 151 | 2006 |
| Genetically engineered T cells to target EGFRvIII expressing glioblastoma SS Bullain, A Sahin, O Szentirmai, C Sanchez, N Lin, E Baratta, ... Journal of neuro-oncology 94, 373-382, 2009 | 97 | 2009 |
| Dementia in the oldest old SS Bullain, MM Corrada CONTINUUM: Lifelong Learning in Neurology 19 (2), 457-469, 2013 | 68 | 2013 |
| Communicating mild cognitive impairment diagnoses with and without amyloid imaging JD Grill, LG Apostolova, S Bullain, JM Burns, CG Cox, M Dick, D Hartley, ... Alzheimer's research & therapy 9, 1-8, 2017 | 63 | 2017 |
| Late-onset Alzheimer disease AL Pierce, SS Bullain, CH Kawas Neurologic clinics 35 (2), 283-293, 2017 | 63 | 2017 |
| Poor physical performance and dementia in the oldest old: the 90+ study SS Bullain, MM Corrada, BA Shah, FH Mozaffar, M Panzenboeck, ... JAMA neurology 70 (1), 107-113, 2013 | 62 | 2013 |
| Chimeric t-cell receptors and t-cells targeting egfrviii on tumors BS Carter, RC Mulligan, S Bullain US Patent App. 12/444,090, 2010 | 61 | 2010 |
| Amyloid imaging and cognitive decline in nondemented oldest‐old: the 90+ Study CH Kawas, DE Greenia, SS Bullain, CM Clark, MJ Pontecorvo, AD Joshi, ... Alzheimer's & Dementia 9 (2), 199-203, 2013 | 56 | 2013 |
| Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial … O Szentirmai, CH Baker, SS Bullain, N Lin, M Takahashi, J Folkman, ... Journal of neurosurgery 108 (5), 979-988, 2008 | 42 | 2008 |
| Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma A Sahin, C Sanchez, S Bullain, P Waterman, R Weissleder, BS Carter PLoS One 13 (7), e0199414, 2018 | 40 | 2018 |
| Sound Body Sound Mind? Physical Performance and the Risk of Dementia in the Oldest‐Old: The 90+ Study SS Bullain, MM Corrada, SM Perry, CH Kawas Journal of the American Geriatrics Society 64 (7), 1408-1415, 2016 | 32 | 2016 |
| What works and what does not work in Alzheimer’s disease? From interventions on risk factors to anti‐amyloid trials S Bullain, R Doody Journal of Neurochemistry 155 (2), 120-136, 2020 | 27 | 2020 |
| The recognition and management of psychological reactions to stroke: A case discussion LS Chriki, SS Bullain, TA Stern Primary care companion to the Journal of clinical psychiatry 8 (4), 234, 2006 | 27 | 2006 |
| P2‐083: AGE OF ONSET OF HYPERTENSION AND RISK OF DEMENTIA IN THE OLDEST‐OLD: THE 90+ STUDY M Corrada, KM Hayden, SS Bullain, A Paganini‐Hill, J DeMoss, C Aguirre, ... Alzheimer's & Dementia 10, P501-P501, 2014 | 14 | 2014 |
| Aphasia: associated disturbances in affect, behavior, and cognition in the setting of speech and language difficulties SS Bullain, LS Chriki, TA Stern Psychosomatics 48 (3), 258-264, 2007 | 14 | 2007 |
| Endothelins: a possible mechanism of cytostatics-induced cardiomyopathy A Zsary, S Szucs, K Keltai, T Schneider, A Rosta, P Sarman, T Fenyvesi, ... Leukemia & lymphoma 45 (2), 351-355, 2004 | 13 | 2004 |
| Endothelin-1 and cardiac function in anthracycline-treated patients: a 1-year follow-up A Zsáry, S Szücs, K Keltai, E Pásztor, T Schneider, A Rosta, P Sármán, ... Journal of Cardiovascular Pharmacology 44, S372-S375, 2004 | 7 | 2004 |
| Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force D Angioni, O Hansson, RJ Bateman, C Rabe, M Toloue, JB Braunstein, ... The Journal of Prevention of Alzheimer's Disease 10 (3), 418-425, 2023 | 6 | 2023 |
